|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | |
| A61P 25/04 |
| (11) | Patento numeris | 2125019 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08709412.4 |
| Europos patento paraiškos padavimo data | 2008-02-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-04-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2008/000521 |
| Data | 2008-02-15 |
| (87) | Numeris | WO 2008/104735 |
| Data | 2008-09-04 |
| (30) | Numeris | Data | Šalis |
| 0703966 | 2007-03-01 | GB |
| (72) |
CHAPLEO, Christopher, Bourne, GB
HYDE, Neil, GB
|
| (73) |
RB Pharmaceuticals Limited,
103-105 Bath Road Slough, Berkshire SL1 3UH,
GB
|
| (54) | IMPROVED MEDICINAL COMPOSITIONS COMPRISING BUPRENORPHINE AND NALTREXONE |
| IMPROVED MEDICINAL COMPOSITIONS COMPRISING BUPRENORPHINE AND NALTREXONE |